NCT03878745View on ClinicalTrials.gov

Comparative User Experiences With BD Nano™ PRO 32G Extra Thin Wall Pen Needle vs the Terumo Nanopass® 34G Pen Needle

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

February 11, 2019

Primary Completion Date

June 14, 2019

Study Completion Date

June 14, 2019

Conditions
Diabetes
Interventions
DEVICE

Terumo Nanopass® 34G pen needle

Insulin pen needle

DEVICE

BD Nano™ PRO 32G pen needle

Insulin pen needle

Trial Locations (2)

94401

Mills-Peninsula Medical Center Dorothy L. and James E Frank Diabetes Research Institute, San Mateo

96814

East West Medical Research Institute, Honolulu

Sponsors
All Listed Sponsors
lead

Becton, Dickinson and Company

INDUSTRY